ArticleMedicina (Kaunas, Lithuania)2023

Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials.

Jhih-Wei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.